PYTHOCANNABINOIDS—PATENTSCOPE SEARCH

Search «pythocannabinoids» at PATENTSCOPE .

http://patentscope.wipo.int/search/en/result.jsf?currentNavigationRow=prev&prevCurrentNavigationRow=2&query=phytocannabinoid&office=&sortOption=Pub%20Date%20Desc&prevFilter=&maxRec=81&viewOption=All

 

E.g.:

20130059018 PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER

«This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.»

GW Pharma Limited

 

08445034 Systems and methods for producing organic cannabis tincture

«Systems and methods are disclosed for fabricating a medicine by preparing a cannabis plant material and classifying the cannabis plant material into an acid, neutral, or analog form; extracting cannabinoids from the cannabis plant material by either a reflux process through evaporating and condensing the cannabis plant material or an ultrasonic extraction process of the cannabis plant material with ultrasonic waves; and infusing the cannabinoids with an alternative emulsion.»

Coles, Jr. Albert L

 

2768493 PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF BREAST CANCER

GW PHARMA LTD

 

WO/2013/182862 SYNERGISTIC THERAPIES OF CANNABIDIOL WITH HYPOTHERMIA FOR NEUROPROTECTION

«The present invention relates to the combination of the phytocannabinoid cannabidiol with therapeutic hypothermia for use in the treatment of neuroprotection or astroprotection.»

GW PHARMA LIMITED

 

2727626 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

«This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.»

GW PHARMA LTD

WO/2013/005017 CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS

«The present invention relates to cannabinoids for use in the prevention or treatment of neurodegenerative diseases or disorders. Preferably the cannabinoids are cannabichromene (CBC) cannabidivarin (CBDV) and / or cannabidivarin acid (CBDVA). More preferably the neurodegenerative disease or disorder to be prevented or treated is Alzheimer’s disease.»

GW PHARMA LIMITED

 

20130280343 Food Products Derived From Cannabinoid-Administered Livestock

«A process, wherein food-producing livestock are administered cannabinoid receptor agonists, is used to induce physiological and/or behavioral effects in the livestock. Food products are then derived from the livestock.»

Roettger Justin Lee

Advertisements